Method for extracting prostatic fluid extracellular vesicles
Through ultrafiltration concentration and size-arrangement column separation technology, high-purity and high-particle size extracellular vesicles are extracted from trace prostate fluid, solving the problem of extraction difficulties in the existing technology and achieving high efficiency and low cost Extracellular vesicle extraction, suitable for prostate cancer diagnosis and research.
Patent Information
- Application Number
- CN202411036336.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-31
- Publication Date
- 2024-11-26
AI Technical Summary
The prior art cannot effectively extract and purify extracellular vesicles from trace prostate fluid, and lacks extracellular vesicles with high purity and uniform particle size for diagnosis and research.
Through ultrafiltration concentration treatment, dissolving in the mobile phase, pretreating the size-based chromatographic column and injecting it into the chromatographic column for separation, high purity and high uniform particle size extraction from 1 ml of prostate fluid.
10μg extracellular vesicles were successfully extracted from 1ml of prostate fluid, with high purity, high separation efficiency and low cost, avoiding vesicles rupture or refusion, and are rich in active substances, suitable for basic research and diagnosis.
Smart Images

Figure CN119020258A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of biomedicine, and in particular to a method for extracting extracellular vesicles from prostatic fluid. Background Art
[0002] Prostatic fluid is a substance secreted by the prostate. Its main components include high concentrations of zinc ions, acid phosphatase, proteolytic enzymes, fibrinolytic enzymes, spermine and aliphatic peptides. These components play an important role in the normal function of sperm and are one of the important components of semen. In addition, prostatic fluid examination is a very valuable test item for the diagnosis of prostate diseases, which usually includes routine examinations and bacterial culture. Through prostatic fluid examination, indicators such as white blood cells, lecithin bodies, and pH values can be detected, thereby helping to diagnose diseases such as prostatitis.
[0003] Extracellular vesicles (EVs) are a type of nano-sized vesicles secreted by cells. They have a lipid bilayer structure and can encapsulate and transport a variety of bioactive molecules such as proteins, nucleic acids, and lipids. These vesicles play an important role in intercellular communication and regulate the function of target cells by delivering these molecules.
[0004] Extracellular vesicles in prostatic fluid have great research value in the diagnosis and treatment of prostate cancer. Currently, there is no method to extract and purify extracellular vesicles from trace amounts of prostatic fluid. Summary of the invention
[0005] The purpose of the present invention is to solve the problem in the prior art that extracellular vesicles cannot be extracted from trace amounts of prostatic fluid and to provide a method for extracting extracellular vesicles from prostatic fluid. The method can extract extracellular vesicles from 1 ml of prostatic fluid, and the obtained extracellular vesicles have the characteristics of high purity and uniform particle size, and can be used for basic research.
[0006] The purpose of the present invention can be achieved by the following technical solutions:
[0007] A method for extracting extracellular vesicles from prostatic fluid, comprising the following specific steps:
[0008] S1, collecting the prostatic fluid to be extracted;
[0009] S2, subjecting the prostatic fluid obtained in step S1 to ultrafiltration and concentration to obtain a concentrated solution;
[0010] S3, dissolving the concentrated solution obtained in step S2 in a mobile phase to obtain a mixed solution;
[0011] S4, pre-treating the size-grouped chromatographic column;
[0012] S5. Injecting the mixed solution obtained in step S3 onto the size-arrayed chromatographic column pretreated in step S4 to obtain prostatic fluid extracellular vesicles.
[0013] Furthermore, in step S2, the steps of ultrafiltration and concentration treatment of prostatic fluid are as follows:
[0014] The prostatic fluid is ultrafiltered and concentrated to a certain amount using an ultrafiltration concentration centrifuge tube to obtain a concentrated solution.
[0015] Furthermore, in the above, the volume ratio of the prostatic fluid to the concentrated solution is 1:0.05-0.15.
[0016] Furthermore, in the above, the volume ratio of the prostatic fluid to the concentrated solution is 1:0.1.
[0017] Furthermore, in step S3, the mobile phase is dimethyl amide.
[0018] Furthermore, in the above, the concentration of the dimethyl amine is 0.5 to 1.5 mL / min.
[0019] Furthermore, in the above, the concentration of dimethyl amine is 1 mL / min.
[0020] Further, in step S4, the method for pretreating the size-grouped chromatographic column is as follows:
[0021] Pass the eluent through the column until the baseline is stable to ensure that the column packing is completely wetted and in equilibrium.
[0022] Furthermore, in step S5, the conditions of the size-arrayed chromatographic column are: temperature of 3 to 5 degrees, flow rate of 0.5 to 1.5 μl / s, and injection volume of 90 to 110 μl.
[0023] Furthermore, the conditions of the size-arrayed chromatographic column are: temperature of 4 degrees, flow rate of 1 μl / s, and injection volume of 100 μl.
[0024] Compared with the prior art, the beneficial effects of the present invention are as follows:
[0025] The present invention provides a method for extracting exosomes from prostate fluid, which solves the problem of extracting extracellular vesicles from trace prostate fluid. The present invention can extract 10 μg of extracellular vesicles from 1 ml of prostate fluid, with high purity, high separation efficiency and low cost. The extracted prostate fluid exosomes contain rich active substances, high total protein content, and rich active substances, avoiding the phenomenon of exosome rupture or re-fusion during the extraction of extracellular vesicles. BRIEF DESCRIPTION OF THE DRAWINGS
[0026] Figure 1This is the morphology of the prostatic fluid extracellular vesicles obtained by the method described in Example 1 of the present invention under an electron microscope.
[0027] Figure 2 This is the particle size distribution diagram of the extracellular vesicles obtained by the method described in Example 1 of the present invention.
[0028] Figure 3 This is an expression diagram of the extracellular vesicle-specific markers CD9, CD63, ALIX and the negative mwrker GM130 obtained by the method described in Example 1 of the present invention. DETAILED DESCRIPTION
[0029] The present invention is described in detail below in conjunction with the accompanying drawings and specific embodiments. This embodiment is implemented based on the technical solution of the present invention, and provides a detailed implementation method and specific operation process, but the protection scope of the present invention is not limited to the following embodiments.
[0030] In conjunction with the accompanying drawings, some embodiments of the present invention are described in detail below. In the absence of conflict, the following embodiments and features in the embodiments may be combined with each other.
[0031] Example 1
[0032] This embodiment provides a method for extracting extracellular vesicles from prostatic fluid, and the specific steps are as follows:
[0033] S1. Collect samples: extract the patient's prostate fluid through anal prostate massage; use ultrafiltration concentration centrifuge tube to concentrate 1ml of prostate fluid to 0.1ml. The ultrafiltration concentrated sample can be stored at -80℃, or quantitatively analyzed using the BCA method for further research or diagnosis.
[0034] S2. Pre-treatment of samples: Dissolve 0.1 ml of ultrafiltered and concentrated prostatic fluid sample in dimethylamine mobile phase to obtain a mixed solution to ensure that the biomolecules in the sample can be evenly distributed and remain stable.
[0035] S3. Prepare the size-grouped chromatographic column: thoroughly clean and pretreat the size-grouped chromatographic column to remove possible hydrophobic impurities; set up the chromatographic system: set the temperature to 4 degrees, the flow rate to 1 μl / s, and the injection volume to 100 μl.
[0036] S4. Loading samples: slowly inject the mixed solution obtained in step S2 into the size-arrayed chromatographic column pretreated in step S3, with each injection volume being 100 μL.
[0037] S5. Enrichment and separation of prostate fluid extracellular vesicles: about 10 μl of prostate fluid extracellular vesicles with high purity and uniform particle size were obtained and stored at 80°C.
[0038] In this embodiment, a detector (such as an ultraviolet spectrum detector) is used to monitor the absorption intensity of each peak in real time and record its position on the chromatographic column. The molecular size corresponding to different peaks is analyzed, and the molecular weight of each peak is usually determined by establishing a standard curve.
[0039] The experimental results are as follows Figure 1-3 As shown, Figure 1 This is the morphology of the prostatic fluid extracellular vesicles obtained by the method described in Example 1 of the present invention under an electron microscope. Figure 2 This is a particle size distribution diagram of the extracellular vesicles obtained by the method described in Example 1 of the present invention. The prostatic fluid extracellular vesicles have high purity and uniform particle size. Figure 3 This is an expression diagram of the extracellular vesicle-specific markers CD9, CD63, ALIX and the negative mwrker GM130 obtained by the method described in Example 1 of the present invention.
[0040] The above description of the embodiments is to facilitate the understanding and use of the invention by those skilled in the art. It is obvious that those skilled in the art can easily make various modifications to these embodiments and apply the general principles described herein to other embodiments without creative work. Therefore, the present invention is not limited to the above embodiments, and improvements and modifications made by those skilled in the art based on the disclosure of the present invention without departing from the scope of the present invention should be within the scope of protection of the present invention.
Claims
1. A method for extracting extracellular vesicles from prostatic fluid, characterized in that: The specific steps are as follows: S1, collecting the prostatic fluid to be extracted; S2, subjecting the prostatic fluid obtained in step S1 to ultrafiltration and concentration to obtain a concentrated solution; S3, dissolving the concentrated solution obtained in step S2 in a mobile phase to obtain a mixed solution; S4, pre-treating the size-grouped chromatographic column; S5. Injecting the mixed solution obtained in step S3 onto the size-arrayed chromatographic column pretreated in step S4 to obtain prostatic fluid extracellular vesicles.
2. The method for extracting extracellular vesicles from prostatic fluid according to claim 1, characterized in that: In step S2, the steps of ultrafiltration and concentration treatment of prostatic fluid are as follows: The prostatic fluid is ultrafiltered and concentrated to a certain amount using an ultrafiltration concentration centrifuge tube to obtain a concentrated solution.
3. A method for extracting extracellular vesicles from prostatic fluid according to claim 2, characterized in that: The volume ratio of the prostatic fluid to the concentrated solution is 1:0.05-0.
15.
4. The method for extracting extracellular vesicles from prostatic fluid according to claim 3, characterized in that: The volume ratio of the prostatic fluid to the concentrated solution is 1:0.
1.
5. The method for extracting extracellular vesicles from prostatic fluid according to claim 1, characterized in that: In step S3, the mobile phase is dimethyl amide.
6. The method for extracting extracellular vesicles from prostatic fluid according to claim 5, characterized in that: The concentration of the dimethyl amine is 0.5-1.5 mL / min.
7. The method for extracting extracellular vesicles from prostatic fluid according to claim 6, characterized in that: The concentration of the dimethyl amine is 1 mL / min.
8. The method for extracting extracellular vesicles from prostatic fluid according to claim 1, characterized in that: In step S4, the method for pretreating the size-grouped chromatographic column is as follows: Pass the eluent through the column until the baseline is stable to ensure that the column packing is completely wetted and in equilibrium.
9. The method for extracting extracellular vesicles from prostatic fluid according to claim 1, characterized in that: In step S5, the conditions of the size-arrayed chromatographic column are: temperature of 3 to 5 degrees, flow rate of 0.5 to 1.5 μl / s, and injection volume of 90 to 110 μl.
10. The method for extracting extracellular vesicles from prostatic fluid according to claim 9, characterized in that: The conditions of the size-arrayed chromatographic column are: temperature of 4 degrees, flow rate of 1 μl / s, and injection volume of 100 μl.
